Hypercalin C - Compound Card

Hypercalin C

Select a section from the left sidebar

Hypercalin C

Structure
Zoomed Structure
  • Family: Plantae - Hypericaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Sesquiterpene
Canonical Smiles C1(=C(C(=C(C(C1=O)(CC=C(C)C)CC=C(C)C)O)C[C@H]1[C@H](CCC1C(=C)C)O)O)C(=O)C(C)C
InChI InChI=1S/C29H42O5/c1-16(2)11-13-29(14-12-17(3)4)27(33)22(15-21-20(18(5)6)9-10-23(21)30)26(32)24(28(29)34)25(31)19(7)8/h11-12,19-21,23,30,32-33H,5,9-10,13-15H2,1-4,6-8H3/t20?,21-,23+/m1/s1
InChIKey BHELRQLSVSYOIH-VBFAWGIDSA-N
Formula C29H42O5
HBA 5
HBD 3
MW 470.65
Rotatable Bonds 9
TPSA 94.83
LogP 6.47
Number Rings 2
Number Aromatic Rings 0
Heavy Atom Count 34
Formal Charge 0
Fraction CSP3 0.59
Exact Mass 470.3
Number of Lipinski Rule Violations 1
# Species Family Kingdom NCBI Taxonomy ID
1 Hypericum riparium Hypericaceae Plantae 269018

Showing of synonyms

  • Tala MF, Talontsi FM, et al. (2015). Antimicrobial and cytotoxic constituents from native Cameroonian medicinal plant Hypericum riparium.. Fitoterapia,2015, 102, 149-155. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CCCC1CC2=CCC(=O)C=C2

Level: 1

Mol. Weight: 470.65 g/mol

Structure

SMILES: O=C1C=CC=CC1

Level: 0

Mol. Weight: 470.65 g/mol

Structure

SMILES: C1CCCC1

Level: 0

Mol. Weight: 470.65 g/mol

Antibacterial

Absorption

Caco-2 (logPapp)
-4.41
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.77
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-3.01

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
1.08
Plasma Protein Binding
84.19
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
5.44
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Toxic
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.86
Biodegradation
Safe
Carcinogenesis
Toxic
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.64
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
6.89
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-79.09
Rat (Acute)
4.88
Rat (Chronic Oral)
3.04
Fathead Minnow
4.87
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
440.29
Hydration Free Energy
-2.75
Log(D) at pH=7.4
3.96
Log(P)
6.86
Log S
-5.08
Log(Vapor Pressure)
-8.26
Melting Point
108.57
pKa Acid
6.99
pKa Basic
2.0
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Type IV / VI secretion system DotU domain-containing protein Q9KN50 Q9KN50_VIBCH Vibrio cholerae serotype O1 3 0.8625
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.8037
Aldo-keto reductase family 1 member C2 P52895 AK1C2_HUMAN Homo sapiens 3 0.7527

Download SDF